Optimized for ease of use
Learn about how the MITRIS valve was designed to optimize usability
Learn more
MITRIS RESILIA Mitral Valve
The tissue valve specifically built for the mitral position
MITRIS RESILIA valve combines advanced features with proven design
- Saddle-shaped sewing cuff mimics the native mitral annulus with an atrialized cuff design to reduce ventricular protrusion
- Lowest profile stents that do not obstruct blood flow through the LVOT
- Largest surgical valve opening and lowest gradients compared to commercially available valves in a pre-clinical study1
- RESILIA tissue preservation technology, designed to enhance durability*2
- Built on the trusted PERIMOUNT valve platform
* Clinical data on valves with RESILIA tissue up to 7-year follow-up have been published, with additional follow-up of up to 10 years in process.
‡The safety and effectiveness of ViV in the MITRIS valve has not been established.
References
- Wang DD, Caranasos TG, O’Neill BP, et al. Comparison of a new bioprosthetic mitral valve to other commercially available devices under controlled conditions in a porcine model. J Card Surg. 2021 Dec;36(12):4654-4662. doi: 10.1111/jocs.16021
- Beaver T, Bavaria J, Griffith B, et al. Seven-year outcomes following aortic valve replacement with a novel tissue bioprosthesis. J Thorac Cardiovasc Surg. 2023;x:1–11.
- Wang DD, O’Neill BP, Caranasos TG, et al. Comparative differences of mitral valve-in-valve implantation: A new mitral bioprosthesis versus current mosaic and epic valves. Catheter Cardiovasc Interv. 2022;99(3):934-942. doi: 10.1002/ccd.30011
Important safety information
Important safety information
MITRIS RESILIA Mitral Valve
Indications: For use in replacement of native or prosthetic mitral heart valves.
Contraindications: There are no known contraindications with the use of the MITRIS RESILIA mitral valve.
Complications and Side Effects: Thromboembolism, valve thrombosis, hemorrhage, hemolysis, regurgitation, endocarditis, structural valve deterioration, nonstructural dysfunction, stenosis, arrhythmia, transient ischemic attack/stroke, congestive heart failure, myocardial infarction, ventricular perforation by stent posts, any of which could lead to reoperation, explantation, permanent disability, and death.
CAUTION: US law restricts this device to sale by or on the order of a physician. See Instructions for Use for full prescribing information, including indications, contraindications, warnings, precautions and adverse events.